Status:
COMPLETED
Description of the Clinical Outcomes of Hospitalized Patients With Heart Failure With Different Serum Potassium Levels
Lead Sponsor:
AstraZeneca
Collaborating Sponsors:
Fudan University
Conditions:
Hyperkalemia
Hypokalemia
Eligibility:
All Genders
Brief Summary
China National Heart Failure Registration Study (CN-HF) is a nationwide, hospital-based, multicentre, prospective registry study sponsored by Ministry of Science and Technology of the People's Republi...
Detailed Description
Blood potassium disorders are a common phenomenon in patients with HF, which may be related to complications of HF (such as decreased potassium intake, renal insufficiency) and medical treatment of HF...
Eligibility Criteria
Inclusion
- HF patients with sK measurements on admission of hospitalization in CN-HF database will be included in this study.
Exclusion
- not available for this study
Key Trial Info
Start Date :
November 30 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 13 2022
Estimated Enrollment :
6950 Patients enrolled
Trial Details
Trial ID
NCT05184998
Start Date
November 30 2021
End Date
July 13 2022
Last Update
July 10 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Shanghai, Shanghai Municipality, China